Intra-aortic Balloon Counterpulsation (IABC) Compliance
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Cardiogenic Shock, IABC Procedure, Intraaortic Balloon Counterpulsation (IABC). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Arterial Compliance as a Predictor of Clinical Outcomes With Intra-aortic Balloon Counterpulsation: A Prospective Observational Pilot Study
Overview
The investigators intend to study how baseline arterial compliance (as defined by stroke volume/pulse pressure) influences the clinical success of intraaortic balloon counterpulsation (IABC) in patients with cardiogenic shock (CS). The investigators aim to compare clinical outcomes in CS patients requiring IABC with normal compliance versus low compliance. The study will enroll patients undergoing IABC that are clinically indicated. Baseline hemodynamic measurements will be obtained and then patients would be stratified based on their compliance. Post IABC, serial hemodynamic measurements will be obtained and compared between groups. Patients will continue to be followed longitudinally until the IABC has been discontinued for any reason. The proposed study will yield results that will aid in developing a larger clinical trial and ultimately assist clinicians in determining if IABC is appropriate therapy for patients in cardiogenic shock.
Detailed description
This study will focus on patients in cardiogenic shock (CS) that will be undergoing clinically indicated intraaortic balloon counterpulsation (IABC) insertion and right heart catheterization. Prior to IABC insertion a patient will have their clinically indicated right heart catheterization. The investigators will record these baseline hemodynamic parameters, including (but not limited to) stroke volume and arterial pulse pressure.
After IABC insertion is completed, repeat hemodynamic measurements will be obtained approximately 30 minutes later. Repeat hemodynamic measurements will be recorded at approximately 3-6 hours following the procedure, and 24 hours following the procedure. The act of recording hemodynamic measurements is part of the usual clinical management of patients with IABC.
The patients will continue be followed longitudinally until their IABC course has completed, either due to resolution of CS, exchange for a separate device, heart transplantation, durable Left Ventricular Assist Device (LVAD) implant, or patient death.
The investigators hypothesize that patients with low arterial compliance will have greater improvements in cardiac output and cardiac filling pressures compared to patients with normal compliance. The specific aims are to (1) compare hemodynamic changes with IABC in cardiogenic shock patients with low compliance vs those with normal compliance and (2) to determine a cutoff value of compliance that can be used for future larger clinical trials.
The proposed study will yield results that will aid in developing a larger clinical trial and ultimately assist clinicians in determining if IABC is appropriate therapy for patients in cardiogenic shock.
Primary outcome measures
- Cardiac Output (L/min) [Time frame: 24 hours]
Secondary outcome measures (12)
- Systolic Blood Pressure (mmHg) [Time frame: 30 minutes]
- Pulmonary Artery Oxygen Saturation (%) [Time frame: 24 hours]
- Ultimate Disposition [Time frame: Longitudinal Follow-Up (approximately 3 months)]
- Total Bilirubin (mg/dL) [Time frame: 24 hours]
- ALT (U/L) [Time frame: 24 hours]
- AST (U/L) [Time frame: 24 hours]
- Creatine Clearance/GFR [Time frame: 24 hours]
- Creatine (mg/dL) [Time frame: 24 hours]
- Lactate millimoles per liter (mmol/L) [Time frame: 24 hours]
- Pulmonary Artery Compliance (mmHg) [Time frame: 24 hours]
- Right Ventricular Stroke Work Index (g·m-²·beat-¹) [Time frame: 24 hours]
- Pulmonary Artery Pulsatility Index (PAPi) [Time frame: 24 hours]
Eligibility criteria
Inclusion criteria
- Age ≥18 years old
- Cardiogenic shock
- Undergoing Intra-aortic Balloon Counterpulsation (IABC) as part of clinical care
- Able to provide consent or have power of attorney or next of kin provide consent
Exclusion criteria
- Age <18 years old
- Unable to consent or does not have power of attorney or next of kin to consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Thomas Jefferson University Hospital — Philadelphia
Identifiers
NCT: NCT07402018 · 2025-0678